Genetic Modifier of the Retinoschisis Gene

视网膜劈裂基因的遗传修饰

基本信息

  • 批准号:
    7189834
  • 负责人:
  • 金额:
    $ 31.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-01 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our studies are specifically focused on understanding the molecular mechanisms causing human retinal diseases associated with synaptic functional and structural defects. X-linked retinoschisis (XLRS) is a common inherited macular degenerative disease caused by mutations in the RS1 gene. In humans, affected individuals show a significant loss in central vision at early stages of life with a splitting of the inner layers of the retina, and a loss in the b-wave of the electroretinogram (ERG). Loss of the b-wave indicates functional abnormalities in the synaptic interactions. Although RS1 function is predicted to be associated with cell adhesion, molecular pathways underlying the disease and the normal function of RS1 are largely unknown. We recently identified a new allele of the mutation in the RS1 mouse ortholog, Rs1h, in 44TNJ mice created by ENU mutagenesis. Synaptic abnormalities as well as severe cell adhesion and retinal laminar structure defects in mutant mice have been observed. In the course of positional cloning, we also identified a single major modifier locus that changes the schisis phenotype and laminar structure abnormality. The goal of this project is to understand the molecular pathway through which the RS1 gene functions using mouse molecular genetic approaches. Our hypothesis is that RS1H maintains the functional and structural integrity of the retinal layers, including the synaptic function, through its role in cell adhesion, which is regulated by genetically and physically interacting factors. In this proposal, our main focus is to identify and characterize the modifier of the Rs1h 1 (Mori) gene. In Aim 1, we will conduct positional cloning to identify the Mori gene. In Aim 2, we will test interaction between RS1H and candidates for RS1H binding proteins. Further, we will test the effect of the modifier gene on phenotypes caused by a mutation in Rs1h and a candidate RS1H binding molecule.
描述(申请人提供):我们的研究重点是了解与突触、功能和结构缺陷相关的导致人类视网膜疾病的分子机制。X连锁视网膜劈裂症(XLRS)是一种常见的遗传性黄斑变性疾病,由RS1基因突变引起。在人类中,受影响的个体在生命的早期阶段表现出严重的中央视力丧失,视网膜内层分裂,视网膜电信号(ERG)的b波丢失。B波的丢失表明突触相互作用的功能异常。虽然RS1的功能被预测与细胞黏附有关,但疾病的分子途径和RS1的正常功能在很大程度上是未知的。我们最近在由ENU突变产生的44TNJ小鼠中发现了RS1小鼠同源突变的一个新的等位基因Rs1h。突触异常以及严重的细胞粘连和视网膜板层结构缺陷已在突变小鼠中观察到。在定位克隆的过程中,我们还发现了一个改变裂隙表型和板层结构异常的主修饰基因座。这个项目的目标是利用小鼠分子遗传学方法了解RS1基因发挥作用的分子途径。我们的假设是,RS1H通过其在细胞黏附中的作用来维持视网膜层的功能和结构的完整性,包括突触功能,这是由遗传和物理相互作用的因素调节的。在这项建议中,我们的主要重点是鉴定和表征Rs1h1(Mori)基因的修饰。在目标1中,我们将进行定位克隆来鉴定Mori基因。在目标2中,我们将测试RS1H与RS1H结合蛋白候选之间的相互作用。进一步,我们将测试修饰基因对Rs1h和候选RS1H结合分子突变引起的表型的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AKIHIRO IKEDA其他文献

AKIHIRO IKEDA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AKIHIRO IKEDA', 18)}}的其他基金

Molecular Genetics of Age-Dependent Retinal Degeneration
年龄依赖性视网膜变性的分子遗传学
  • 批准号:
    10221685
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Genetic Factors Affecting Aging of the Retina
影响视网膜老化的遗传因素
  • 批准号:
    8429730
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Molecular Genetics of Age-Dependent Retinal Degeneration
年龄依赖性视网膜变性的分子遗传学
  • 批准号:
    9975162
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Molecular Genetics of Age-Dependent Retinal Degeneration
年龄依赖性视网膜变性的分子遗传学
  • 批准号:
    10459299
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Molecular Genetics of Age-Dependent Retinal Degeneration
年龄依赖性视网膜变性的分子遗传学
  • 批准号:
    10657857
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Molecular Genetics of Age-Dependent Retinal Degeneration
年龄依赖性视网膜变性的分子遗传学
  • 批准号:
    8689046
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Molecular Genetics of Age-Dependent Retinal Degeneration
年龄依赖性视网膜变性的分子遗传学
  • 批准号:
    8371412
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Molecular Genetics of Age-Dependent Retinal Degeneration
年龄依赖性视网膜变性的分子遗传学
  • 批准号:
    8519458
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Genetic Factors Affecting Aging of the Retina
影响视网膜老化的遗传因素
  • 批准号:
    8586265
  • 财政年份:
    2012
  • 资助金额:
    $ 31.87万
  • 项目类别:
Genetic Modifier of the Retinoschisis Gene
视网膜劈裂基因的遗传修饰
  • 批准号:
    7388134
  • 财政年份:
    2006
  • 资助金额:
    $ 31.87万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 31.87万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 31.87万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 31.87万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 31.87万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 31.87万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 31.87万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 31.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 31.87万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 31.87万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 31.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了